Covid-19 Antibody Drugs
- All
- News
- Videos
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibodies, Vaccines Less Effective Against Coronavirus Variants: Study
COVID-19 antibody-based drugs and vaccines developed so far may become less effective as new variants of the novel coronavirus spread widely, according to a new study.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
-
2 New Medicines For Covid Treatment Get WHO Approval
Eli Lilly & Co.'s rheumatoid arthritis drug and GlaxoSmithKline Plc's monoclonal antibody won the backing of World Health Organization experts for treating Covid-19 as new infections surge across the globe.
-
European Union To Approve First Covid Antibody Drugs Amid Spike In Cases
The European Union drugs regulator is set to authorise the use of two monoclonal antibodies to treat COVID-19 patients in coming days, two EU sources told Reuters, in its first approvals of such therapies.
-
AstraZeneca Says Its Antibody Cocktail Prevents Covid In High-Risk Groups
AstraZeneca Plc's Covid-19 antibody cocktail was found to be 77% effective in preventing symptomatic Covid-19 in high-risk people in a key trial that could expand the range of drugs available to vulnerable groups.
-
Covid Antibody Cocktail, Used To Treat Donald Trump, Comes To India. It Costs...
Drug major Roche India on Monday announced the launch of its first batch of antibody cocktail against COVID-19 in India. The antibody cocktail -- Casirivimab and Imdevimab -- is priced at Rs 59,750 per dose. Roche's antibody cocktail was given to for
-
Antibodies, Vaccines Less Effective Against Coronavirus Variants: Study
COVID-19 antibody-based drugs and vaccines developed so far may become less effective as new variants of the novel coronavirus spread widely, according to a new study.
-
Antibody Therapy Given To Trump For Covid Gets US Emergency Approval
A Covid-19 antibody therapy used to treat President Donald Trump was approved by the US drug regulator on Saturday for people who aren't yet hospitalized by the disease but are at high risk.
-
US Allows Emergency Use Of First COVID-19 Antibody Drug
U.S. regulators on Monday authorized emergency use of the first experimental antibody drug for COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions.
-
WHO-Led Covid Drug Scheme Doubles Down On Antibodies, Steroids And Shuns Remdesivir
A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead's remdesivir blockbuster therapy, an internal document shows.
-
Lilly's COVID-19 Drug Could Be Ready For Use As Soon As September
Eli Lilly and Co could have a drug specifically designed to treat COVID-19 authorized for use as early as September if all goes well with either of two antibody therapies it is testing, its chief scientist told Reuters on Wednesday.
-
Promising COVID-19 Vaccine Sends Drug Firm's Shares Soaring
Moderna Inc said on Monday its experimental COVID-19 vaccine showed promise in a small early-stage trial, with the vaccine producing virus-neutralizing antibodies similar to that found in recovered patients, sending shares soaring 25%.
